Authors: Van Aerts, LAGJM Mallaret, M Rigter, H

Citation: Lagjm. Van Aerts et al., N-methyl-1-(1,3-benzodioxol-5-yl)-2-buta (MBDB): its properties and possible risks, ADDICT BIOL, 5(3), 2000, pp. 269-282

Authors: Hardy, G Saviuc, P Danel, V Lafond, JL Mallaret, M

Citation: G. Hardy et al., Bromide poisoning and false hyperchloraemia., ANN FR A R, 19(5), 2000, pp. 363-366

Authors: Vincent, F Bessard, J Vacheron, J Mallaret, M Bessard, G

Citation: F. Vincent et al., Determination of buprenorphine and norbuprenorphine in urine and hair by gas chromatography-mass spectrometry, J ANAL TOX, 23(4), 1999, pp. 270-279

Authors: Piquet, C Mallaret, M Bontemps, H Fabre, M Sarrot-Reynaud, F Imbert, B

Citation: C. Piquet et al., Adverse drug reactions and medication errors: the place of the organization of drugs distribution, THERAPIE, 54(1), 1999, pp. 49-53

Authors: Cracowski, JL Mallaret, M Vanzetto, G

Citation: Jl. Cracowski et al., Myocardial infarction associated with buprenorphine, ANN INT MED, 130(6), 1999, pp. 537-537